The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races-Reference-Cited by-同舟云学术

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

Published:2007 Issue: Volume:16 Page:72-77
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kurebayashi Junichi,Moriya Takuya,Ishida Takanori,Hirakawa Hisashi,Kurosumi Masafumi,Akiyama Futoshi,Kinoshita Takayuki,Takei Hiroyuki,Takahashi Kaoru,Ikeda Masahiko,Nakashima Kazutaka

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference30 articles.

1. Breast cancer control: signs of progress, but more work required;Boyle;Breast,2005

2. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes?;Blackman;J Clin Oncol,2006

3. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older;Li;Cancer Epidemiol Biomarkers Prev,2002

4. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma;Porter;Cancer,2004

5. Ethnicity and breast cancer: factors influencing differences in incidence and outcome;Chlebowski;J Natl Cancer Inst,2005

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis;Journal of Breast Disease;2023-12-01

2. Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer;Breast Cancer;2023-10-04

3. Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study;Translational Breast Cancer Research;2023-01

4. Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years;JCO Global Oncology;2022-05

5. Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years;JCO GLOB ONCOL;2022